R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

Germany's Merck KGaA has said it needs to double the productivity of its R&D operations, with the aim of launching a new product every 18 months on average, to boost its pharma business.

CSIRO, Australia's national science agency, is calling for expressions of interest for ' Innovate to Grow: Queensland ', a ...

The Strategic Examination of R&D discussion paper reveals that local investment in R&D is now only 1.66% of GDP — well below ...

The Australian Industry Group (Ai Group) has welcomed the release of the Strategic Examination of R&D Discussion Paper, emphasising the critical need ...